Inventory of Supplemental Information:
5 Supplemental Figures: Figure S1 : TIGIT+ regulatory T cells display an activated phenotype. Table S1 : Differentially regulated genes in TIGIT-vs. TIGIT+ Tregs 2) were sorted and co-cultured at a ratio of 1:10 under Th1, Th2, or Th17 polarizing conditions. On day 5 cells were re-stimulated with PMA/Ionomycin and cytokine levels in CD45.1 + T effector cells were determined by flow cytometry. A representative experiment is shown (mean ± SEM). In vivo antibody treatment. Mice were immunized s.c. with 200 µl of an emulsion containing 100 µg of MOG 35-55 peptide (MEVGWYRSPFSRVVHLYRNGK) in adjuvant oil (CFA) on day 0 and treated i.p. with 100 µg of anti-TIGIT (clone 4D4) or isotype control Ab (armenian hamster IgG) on days 0, 2, 4, 10 and 17. Spleens and lymph nodes were collected on day 10 and 2.5 x 10 6 cells / ml were re-stimulated in the presence of a range of concentrations of MOG 35-55 peptide (0.07 µg/ml -50 µg/ml). After 48 h, plates were pulsed with 1 µCi/well 3 H-thymidine and incubated for an additional 18h before being harvested onto glass fiber filters.
3 H-thymidine incorporation was analyzed using a β-counter (1450 Microbeta, Trilux, Perkin Elmer).
In vitro Treg differentiation. CD4
+ T cells from WT or TIGIT -/-mice were isolated using anti-CD4 beads (Miltenyi). Naïve CD4 + CD62L + CD44 -cells were sorted by flow cytometry and stimulated with plate bound anti-CD3 (145-2C11, 0.3 µg/ml) and anti-CD28 (PV-1, 2 µg/ml) in the presence of 2.5ng/ml TGF-β (R&D) and where indicated 10µg/ml recombinant Fgl2 (a kind gift from Gary Levy, University of Toronto). Foxp3 expression was assessed by flow cytometry 4 days later.
In vivo suppression. CD4 + T cell from CD45.1 mice and CD4 + CD25 + Tregs from WT or Fgl2 -/-mice were purified by cell sorting after enrichment for CD4 + cells using anti-CD4 MACS beads. CD45.1 CD4 + T cell were labeled with CFSE and transferred i.v. into RAG1 -/-mice, either alone or with Tregs (5:1 effector T cell/Treg ratio). On day 8 mice were sacrificed and CFSE dilution in CD45.1 + effector T cells was analyzed by flow cytometry.
